Live Kabra Drugs Share Price Chart

O 7.91

H 7.91

L 7.91

VOL 73407

Kabra Drugs Performance

Days Range

Low: ₹7.91
High: ₹7.91
Previous Close ₹7.54
Open ₹7.91
Volume 74,838
Day’s Range ₹7.91 - ₹7.91
52W Range ₹3.18 - ₹7.91
Market Cap ₹3.47 Cr

Kabra Drugs Fundamentals

ROCE (TTM) -26.3712
P/E Ratio (TTM) 0
P/B Ratio 3.22
Industry P/E 45.07
Debt to Equity 1.58
ROE -67.9749
EPS (TTM) 0
Dividend Yield 0
Book Value 2.46
Face Value 10

Kabra Drugs Financials

Jun 2023Sep 2023Dec 2023Mar 2024
Net Sales0000
Expenses0.120.130.110.37
Profit before tax-0.12-0.13-0.11-0.37
Operating Profit-0.12-0.13-0.11-0.37
Net Profit-0.12-0.13-0.11-0.37
EPS in Rs-0.28-0.31-0.25-0.84

About Kabra Drugs

Kabra Drugs Ltd was incorporated as a Limited Company on August 22, 1989. The Company has set up a Unit at Indore for manufacturing of Ether derivatives which includes Diethyl Ether (Anesthesia), Solv ... Read More

Parent Organisation Indian Private
Founded 1989
Managing Director
BSE Symbol KABRADG

Peer Comparison

Stocks Market Cap (cr) Market Price (₹) 52 Week Low-High (₹)
Supriya Lifescience Ltd ₹3,084.50

400.9

16.90 (4.40%)

382 - 402.95View Peer Comparison
Celestial Biolabs Ltd ₹4.56

1.75

0.00 (0.00)

1.75 - 1.8View Peer Comparison
JFL Life Sciences Ltd ₹45.09

40

1.00 (-2.44%)

40 - 40View Peer Comparison
Procter & Gamble Health Ltd ₹8,280.25

4989.2

0.35 (-0.01%)

4932.1 - 5014.5View Peer Comparison
Veerhealth Care Ltd ₹42.12

26

0.00 (0.00)

26 - 26View Peer Comparison

What's Trending

Kabra Drugs FAQs

What is the Share price of Kabra Drugs (KABRADG)?

Kabra Drugs (KABRADG) share price as of June 10, 2024, on BSE is Rs 7.91 (BSE).

Can I buy Kabra Drugs (KABRADG) shares?

Yes, You can buy Kabra Drugs (KABRADG) shares by opening a Demat account with Angel One.

How do I buy Kabra Drugs (KABRADG) from Angel One?

Kabra Drugs (KABRADG) share can be brought through the following modes:
  1. Direct investment: You can buy Kabra Drugs (KABRADG) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Kabra Drugs (KABRADG) shares.